Amedeo Smart

Free Medical Literature Service

 

Amedeo

Malignant Melanoma
  Free Subscription

Articles published in
Eur J Dermatol
    December 2023
  1. SONG T, Tan C, Liu Y, Xue YN, et al
    Dermoscopic and reflectance confocal microscopy features of Netherton syndrome.
    Eur J Dermatol. 2023;33:696-697.
    >> Share

  2. LANGBOUR C, Law-Wan J, Ben-Saad R, Zaragoza J, et al
    Intramedullary spinal cord metastasis: a rare complication of malignant melanoma.
    Eur J Dermatol. 2023;33:694-696.
    >> Share

    October 2023
  3. FUKUCHI K, Shimauchi T, Fujiyama T, Ito T, et al
    A case of bullous pemphigoid in a malignant melanoma patient following an increased Th2/Th1 ratio in peripheral blood cells after nivolumab treatment.
    Eur J Dermatol. 2023;33:550-551.
    >> Share

  4. KIM PJ, Lansang RP, Ko E, Abu-Hilal M, et al
    Incidence of melanoma and non-melanoma skin cancer in patients with celiac disease: a systematic review and meta-analysis.
    Eur J Dermatol. 2023;33:506-513.
    >> Share

  5. VAN DIEREN L, Amar JZ, Geurs N, Quisenaerts T, et al
    Unveiling the power of convolutional neural networks in melanoma diagnosis.
    Eur J Dermatol. 2023;33:495-505.
    >> Share

    June 2023
  6. SAMELA T, Fania L, Sampogna F, Mastroeni S, et al
    Incidence of keratinocyte carcinomas in Italy: an exercise in indirect estimation based on melanoma data.
    Eur J Dermatol. 2023;33:230-234.
    >> Share

  7. IBRAHIM N, Ali SR, Dobbs TD, Gibson AGJ, et al
    The incidence of non-melanoma skin cancer in the UK and the Republic of Ireland: a systematic review.
    Eur J Dermatol. 2023;33:218-229.
    >> Share

    April 2023
  8. GARCIA-PIQUERAS P, Aviles-Izquierdo JA
    Clues in Dermoscopy. Epidermotropic cutaneous malignant melanoma metastases: a description of 25 cases.
    Eur J Dermatol. 2023;33:190-192.
    >> Share

  9. PIROTH M, Goronflot T, Samaran R, Varey E, et al
    Panniculitis does not predict clinical response in patients with advanced melanoma under targeted therapy.
    Eur J Dermatol. 2023;33:126-136.
    >> Share

  10. BELLINATO F, Moar A, Rosina P, Gisondi P, et al
    Comparative dermoscopy assessment of nevus-associated versus de novo in situ melanoma.
    Eur J Dermatol. 2023;33:121-125.
    >> Share

  11. CHARPENTIER C, Riche VP, Nguyen JM, Guile R, et al
    Analysis of cost-effectiveness of chemotherapeutic agents and new therapies for the management of unresectable and metastatic melanoma.
    Eur J Dermatol. 2023;33:81-86.
    >> Share

  12. FRENARD C, Blanchet K, Lecerf P, Varey E, et al
    Machine learning algorithm to predict response to immunotherapy in real-life settings for patients with advanced melanoma.
    Eur J Dermatol. 2023;33:75-80.
    >> Share

    November 2022
  13. ECKARDT J, Behrens V, Kofler K, Forchhammer S, et al
    The impact of haematoxylin-eosin staining and immunohistochemistry of lentigo maligna and lentigo maligna melanoma margins on local recurrence.
    Eur J Dermatol. 2022;32:750-755.
    >> Share

  14. ZOUTENDIJK J, Siem D, Argenziano G, Forsea AM, et al
    The daily use of dermoscopy in the Netherlands.
    Eur J Dermatol. 2022;32:736-742.
    >> Share

  15. L'ORPHELIN JM, Le Naour S, Dalle S, Varey E, et al
    Epidemiology and characteristics of acral lentiginous melanoma compared to lentigo melanoma in France: a multicentric retrospective study from the French cohort RIC-Mel database.
    Eur J Dermatol. 2022;32:691-697.
    >> Share

  16. RICCI F, Fania L, Antonelli F, Ricci F, et al
    Melanoma on tattoos: a case study and review of the literature.
    Eur J Dermatol. 2022;32:703-708.
    >> Share

  17. PAPANIKOLAOU ES, Sampogna F, Fania L, Di Lella G, et al
    Quality of life in caregivers of melanoma patients.
    Eur J Dermatol. 2022;32:698-702.
    >> Share

    September 2022
  18. SPURNY-DWORAK J, Steiner A, Breier F, Stella A, et al
    Effects of the COVID-19 pandemic on the diagnosis of malignant melanoma: a retrospective study.
    Eur J Dermatol. 2022;32:615-617.
    >> Share

    July 2022
  19. TEUSCHER M, Diehl K, Schaarschmidt ML, Weilandt J, et al
    Effects of the COVID-19 pandemic on care of melanoma patients in Berlin, Germany: the Mela-COVID survey
    Eur J Dermatol. 2022;31:521-529.
    >> Share

  20. GAMO-VILLEGAS R, Floristan-Muruzabal U, Pampin-Franco A, Martin-Alcalde J, et al
    Dermoscopic changes in 22 extrafacial in situ and invasive lentiginous melanomas
    Eur J Dermatol. 2022;32:516-521.
    >> Share

    May 2022
  21. YANG L, Wang T, Liu YH
    A Chinese case of amelanotic lentigo maligna melanoma
    Eur J Dermatol. 2022;32:410-411.
    >> Share

    April 2022
  22. SUHONEN V, Siiskonen H, Suni M, Rummukainen J, et al
    Malignant and in situ subtypes of melanoma are associated with basal and squamous cell carcinoma and its precancerous lesions
    Eur J Dermatol. 2022;32:187-194.
    >> Share

    February 2022
  23. SUYAMA T, Nishimura T, Yokoyama M, Matsuki Y, et al
    Paediatric spitzoid melanoma diagnosed with the aid of fluorescence in situ hybridization and mutation analysis.
    Eur J Dermatol. 2022 Feb 15. pii: ejd.2022.4208. doi: 10.1684/ejd.2022.4208.
    >> Share

  24. AMABILE S, Tonella L, Rubatto M, Argenziano G, et al
    Clinical evaluation of hydration index using a corneometer in metastatic melanoma patients treated with BRAF/MEK inhibitors: a prospective study.
    Eur J Dermatol. 2022 Feb 11. pii: ejd.2022.4198. doi: 10.1684/ejd.2022.4198.
    >> Share

    January 2022
  25. SUYAMA T, Nishimura T, Yokoyama M, Matsuki Y, et al
    Paediatric spitzoid melanoma diagnosed with the aid of fluorescence.
    Eur J Dermatol. 2022;32:134-135.
    >> Share

  26. AMABILE S, Tonella L, Rubatto M, Argenziano G, et al
    Clinical evaluation of hydration index using a corneometer in metastatic melanoma patients treated with BRAF/MEK inhibitors: a prospective study.
    Eur J Dermatol. 2022;32:126-127.
    >> Share

  27. SUYAMA T, Nishimura T, Yokoyama M, Matsuki Y, et al
    Paediatric spitzoid melanoma diagnosed with the aid of fluorescence.
    Eur J Dermatol. 2022;32:134-135.
    >> Share

  28. AMABILE S, Tonella L, Rubatto M, Argenziano G, et al
    Clinical evaluation of hydration index using a corneometer in metastatic melanoma patients treated with BRAF/MEK inhibitors: a prospective study.
    Eur J Dermatol. 2022;32:126-127.
    >> Share

    December 2021
  29. DUARTE AF, Sousa-Pinto B, Azevedo LF, Barros AM, et al
    Clinical ABCDE rule for early melanoma detection.
    Eur J Dermatol. 2021;31:771-778.
    >> Share

  30. LACOMBE M, Bedane C, Delaumenie S, Bernard P, et al
    Nivolumab-induced multiple morphea associated with eosinophilic fasciitis.
    Eur J Dermatol. 2021;31:844-846.
    >> Share

    November 2021
  31. RUBIO-CASADEVALL J, Carbo-Bague A, Puigdemont M, Osca-Gelis G, et al
    Population-based analysis of the prevalence of BRAF mutation in patients diagnosed with cutaneous melanoma and its significance as a prognostic factor.
    Eur J Dermatol. 2021 Nov 17. pii: ejd.2021.4136. doi: 10.1684/ejd.2021.4136.
    >> Share

  32. BUJA A, De Luca G, Zorzi M, Carpin E, et al
    Quality management of cutaneous melanoma: impact on short-term outcomes and costs.
    Eur J Dermatol. 2021 Nov 17. pii: ejd.2021.4149. doi: 10.1684/ejd.2021.4149.
    >> Share

    October 2021
  33. MAEDA T, Hiura A, Uehara J, Toyoshima R, et al
    Real-world efficacy of nivolumab plus ipilimumab combination therapy versus nivolumab monotherapy for Stage IV melanoma patients in Asia.
    Eur J Dermatol. 2021 Oct 7. pii: ejd.2021.4139. doi: 10.1684/ejd.2021.4139.
    >> Share

  34. GARCIA-PIQUERAS P, Aviles-Izquierdo JA, Almodovar-Real A, Nieto-Benito LM, et al
    Clues in dermoscopy: White and yellow structures in balloon cell melanoma.
    Eur J Dermatol. 2021;31:676-677.
    >> Share

  35. NEUBERGER A, Menzer C, Volk N, Enk AH, et al
    Expression of p53 up-regulated modulator of apoptosis (PUMA) in non-melanoma skin cancer of long-term immunosuppressed solid organ transplant recipients compared to immunocompetent patients.
    Eur J Dermatol. 2021;31:609-615.
    >> Share

    August 2021
  36. SENDIN-MARTIN M, Duran-Romero AJ, Martin-Carrasco P, Conejo-Mir J, et al
    Mortality associated with non-melanoma skin cancer in Spain from 1979 to 2018: trends and age-adjusted rates.
    Eur J Dermatol. 2021 Aug 26. pii: ejd.2021.4110. doi: 10.1684/ejd.2021.4110.
    >> Share

  37. ARAUJO BLC, De Oliveira JL, Correa FM, Fontes LES, et al
    General anaesthesia versus other types of anaesthesia in patients undergoing surgery for treatment of cutaneous melanoma: a systematic review and meta-analysis.
    Eur J Dermatol. 2021 Aug 26. pii: ejd.2021.4109. doi: 10.1684/ejd.2021.4109.
    >> Share

  38. TEUSCHER M, Diehl K, Schaarschmidt ML, Weilandt J, et al
    Effects of the COVID-19 pandemic on care of melanoma patients in Berlin, Germany: the Mela-COVID survey.
    Eur J Dermatol. 2021 Aug 26. pii: ejd.2021.4098. doi: 10.1684/ejd.2021.4098.
    >> Share

  39. BOADA A, Tejera-Vaquerizo A, Requena C, Manrique-Silva E, et al
    Association between melanoma thickness and clinical and demographic characteristics.
    Eur J Dermatol. 2021 Aug 26. pii: ejd.2021.4096. doi: 10.1684/ejd.2021.4096.
    >> Share

  40. DONZEL M, Harou O, Skowron F, Dalle S, et al
    Acral lentiginous melanoma with HER2/ErbB2 amplification.
    Eur J Dermatol. 2021;31:588-590.
    >> Share

  41. GEDEAH C, Damsin T, Absil G, Somja J, et al
    The impact of COVID-19 on the new diagnoses of melanoma.
    Eur J Dermatol. 2021;31:565-567.
    >> Share

  42. SAMARAN R, L'Orphelin JM, Dreno B, Rat C, et al
    Interest in artificial intelligence for the diagnosis of non-melanoma skin cancer: a survey among French general practitioners.
    Eur J Dermatol. 2021;31:457-462.
    >> Share

    June 2021
  43. ARNE V, Canan G, Marjan G
    A narrative review on the outcome of primary cutaneous melanomas arising in solid organ transplant recipients.
    Eur J Dermatol. 2021 Jun 2. pii: ejd.2021.4067. doi: 10.1684/ejd.2021.4067.
    >> Share

  44. POZSGAI M, Nemeth K, Olah P, Gyulai R, et al
    The significance of imaging examinations during follow-up for malignant melanoma.
    Eur J Dermatol. 2021;31:357-363.
    >> Share

  45. MASSON L, Poizeau F
    sQuiz your knowledge! A cutaneous nodule in an HIV-positive man returning from Thailand.
    Eur J Dermatol. 2021;31:436-437.
    >> Share

    April 2021
  46. BANCALARI B, Ferrer-Guillen S, Tejera-Vaquerizo A, Requena C, et al
    Longitudinal study of prognostic factors for localized cutaneous melanoma in patients who have been disease-free for five years.
    Eur J Dermatol. 2021 Apr 19. pii: ejd.2021.4022. doi: 10.1684/ejd.2021.4022.
    >> Share

  47. SCARD C, Nguyen JM, Varey E, Moustaghfir I, et al
    Cardiac adverse events associated with anti-PD-1 therapy in patients treated for advanced melanoma: relevance of dosing troponin T levels.
    Eur J Dermatol. 2021 Apr 2. pii: ejd.2021.4009. doi: 10.1684/ejd.2021.4009.
    >> Share

  48. JOVIC A, Tiodorovic D, Popovic D, Vidovic N, et al
    Multiple eruptive squamous cell carcinomas: a possible clinical sign in melanoma patients treated with vemurafenib.
    Eur J Dermatol. 2021;31:279-280.
    >> Share

  49. KACZMARCZYK R, King F, Tizek L, Biedermann T, et al
    Visualising the past to plan the future: a network analysis of the largest European dermatology conference.
    Eur J Dermatol. 2021;31:161-169.
    >> Share

  50. RODRIGUEZ-LOMBA E, Lozano-Masdemont B, Sanchez-Herrero A, Suarez-Fernandez R, et al
    Dermsurgery: Reconstruction of a large dorsal hand defect with a dermal substitute matrix.
    Eur J Dermatol. 2021;31:302-304.
    >> Share

    March 2021
  51. MILLAN-ESTEBAN D, Garcia-Casado Z, Manrique-Silva E, Viros A, et al
    Distribution and clinical role of KIT gene mutations in melanoma according to subtype: a study of 492 Spanish patients.
    Eur J Dermatol. 2021 Mar 1. pii: ejd.2021.3971. doi: 10.1684/ejd.2021.3971.
    >> Share

    February 2021
  52. RUSSO I, Filoni A, Alaibac M
    Persistence of superficial basal cell carcinoma during pembrolizumab treatment for metastatic melanoma.
    Eur J Dermatol. 2021 Feb 12. pii: ejd.2020.3958. doi: 10.1684/ejd.2020.3958.
    >> Share

    December 2020
  53. LUDWIG SV, F Cheng P, Mangana J, Braun R, et al
    Survival and therapeutic response in patients with melanoma of unknown and known primary: a single-centre retrospective analysis.
    Eur J Dermatol. 2020;30:699-709.
    >> Share

    November 2020
  54. MORA-FERNANDEZ V, Boada A, Manzano JL, Jaka A, et al
    Locally advanced head and neck squamous cell carcinoma and melanoma simultaneously treated with pembrolizumab: an unusual situation.
    Eur J Dermatol. 2020 Nov 24. pii: ejd.2020.3911. doi: 10.1684/ejd.2020.3911.
    >> Share

    October 2020
  55. GRAN F, Weber J, Schummer P, Kneitz H, et al
    Sarcoidosis developing upon immune checkpoint inhibition in advanced uveal melanoma.
    Eur J Dermatol. 2020;30:629-631.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016